Delix Therapeutics

a clinical-stage neuroscience company pioneering the discovery and development of neuroplastogens

Amount raised

$100M

Round

Series C

Date raised

November 9, 2026

Founded

—

CompanyDelix Therapeutics

IndustryBiotechnology

InvestorsJohnson & Johnson, SV Health Investors’ Dementia Discovery Fund (DDF)

Get new raises like this every week

Free weekly list of newly funded startups and their founders.

a clinical-stage neuroscience company pioneering the discovery and development of neuroplastogens

How much did Delix Therapeutics raise?: Delix Therapeutics raised $100M in a Series C round on November 9, 2026. Investors include Johnson & Johnson, SV Health Investors’ Dementia Discovery Fund (DDF).
Who founded Delix Therapeutics?: No founder is listed for Delix Therapeutics yet.